MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell Lung Cancer Treatment Outcomes

Figure 1

The Kaplan-Meier survival curve of selected SNPs and the RPA classification in patients with limited-disease small cell lung cancer treated with curative chemoradiotherapy. (a) PIK3R1: rs12755 (A>C); (b) MTOR: rs2536 (T>C); (c) PIK3R1: rs3756668 (A>G); (d) RPA classification.

(a)

(b)

(c)

(d)